Controversy over Outsourcing Drug Clinical Trials to India

Many U.S. technology jobs have been outsourced to India, and now there are reports medical research is being transferred there, too. Clinical trials that cost millions in the United States cost only thousands to perform in India. It's raising questions about the ethics of using subjects who have little exposure to Western medicine, and whether they're fully aware of the risks and benefits of participating in drug trials. One issue: There may be no benefit to those suffering illness in India if the drugs being tested are too expensive for poor Indians to afford. Reporter Fred de Sam Lazaro of Twin Cities Public Television reports.

Copyright © 2004 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

Copyright © 2004 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.